Cancer is an increasingly urgent global health issue. By 2030, the global cancer burden is projected to grow by 70 percent, and more than two-thirds of cancer deaths are occurring in low- and middle-income countries. Yet only 2 percent of health funding in these countries is directed toward cancer and other noncommunicable diseases. Many of the highest-burden cancers in these regions are associated with infectious diseases, including HIV, human papillomavirus and viral hepatitis.
Fred Hutch has a growing cross-divisional Global Oncology program that investigates globally relevant cancers and seeks to understand the varied genetics and biology of common cancers around the world. We aim to develop high-impact, low-cost diagnostic tools and therapies that can be used in low-resource settings worldwide.